Abstract:Purpose: To evaluate characteristics of obstructions of the hepatic veins (HVs) in Chinese patients, technical aspects of puncture of the HVs, short- and mid-term outcomes, and complications of endovascular treatment.Patients and Methods: Forty-eight HV patients with different degrees of symptoms and signs of portal hypertension were enrolled in our study. Endovascular treatments with balloon and stents were performed. Catheter-directed thrombolysis (CDT) was performed in patients with thrombosis in the HVs. For patients with lesions of both the HVs and the inferior vena cava (IVC), balloon expansions or stenting were performed at the IVC lesions also.Results: Endovascular treatments were successful in 43 patients. The technically success rate was 89.6% (43/48). Fifteen patients underwent solely balloon expansions, 28 patients had balloon expansions and stentings, 5 patients underwent CDT, and 3 patients had implanted stents in the IVC lesions at the same time. The symptoms of portal hypertension were alleviated in 39 patients postoperatively. In the other 4 cases portal hypertension was mildly alleviated at discharge. Thirty-nine of the 43 patients were followed up for an average of 24 +/- 1.3 months (range, 6-62 months). Ascites were completely resolved in 32 cases, with a small amount of ascites in 4 patients and moderate to massive amounts in 3 patients. Hepatomegaly and splenomegaly completely disappeared in 30 patients and still could be touched in 6 patients. The HVs were patent in 29 patients. Restenosis and re-occlusion of the HVs appeared in 4 cases. All patients were successfully treated by endovascular treatments.Conclusions: Endovascular treatments for patients with obstruction of the HVs have a high technical success rate, fewer complications, and better short- and mid-term clinical outcome. The key to successful endovascular treatment is successful puncture of HVs. For patients who have occlusive lesions of HVs combined with occlusive IVC, recanalization of the lesions of the HVs could achieve good results.

The analysis of misdiagnosis and mistreatment in Budd-Chiari syndrome with hepatic vein obstruction

Staged Management of Budd-Chiari Syndrome Caused by Co-Obstruction of the Inferior Vena Cava and Main Hepatic Veins.

Endovascular Treatment Of Budd-Chiari Syndrome With Hepatic Vein Obstruction In China

Endovascular treatment of Budd-Chiari syndrome with occlusion of hepatic veins

Balloon Angloplasty and Stenting of Hepatic Veins for the Treatment of Budd-Chiari Syndrome Caused by Long Segmental Occlusion of the Inferior Vena Cava (IVC)

Significance of accessory hepatic vein pressure reduction in treatment of Budd-Chiari syndrome

INTERVENTIONAL OR SEMI-INTERVENTIONAL TREATMENT FOR BUDD-CHIARI SYNDROME

The diagnosis and treatment of Budd-Chiari syndrome with inferior vena cava thrombosis

Discrimination between Budd-Chiari Syndrome,Hepatic Veno Occlusive Disease and Liver Cirrhosis

Analysis of Surgical Treatment Results in 120 Cases of Budd-Chiari Syndrome

Interventional Treatment of Budd-Chiari Syndrome:Report of 312 Cases

Clinical Analysis of 50 Cases of Hepatic Veno-Occlusive Disease

Interventional Endovascular Treatment for Budd-Chiari Syndrome Using Percutaneous Transluminal Angioplasty and Stents

Radical Surgery under Genuine Direct Vision for the Treatment of Budd-Chiari Syndrome.

Inferior Vena Cava Dilatation and Stent Implantation Combined with Splenorenal Shunt to Treat Budd-Chiari Syndrome

Modified Transjugular Intrahepatic Portosystemic Shunt In The Treatment Of Budd-Chiari Syndrome

Interventional and Surgical Treatment of Budd-Chiari Syndrome: A Report of 39 Cases

Budd-Chiari Syndrome： Diagnosis with Three-Dimensional Contrast-Enhanced Magnetic Resonance Angiography

Point-of-care ultrasound in the diagnosis and treatment of Budd-Chiari syndrome: A rare case report and literature review

[Radical Surgery for Budd-Chiari Syndrome Through Exposure of the Whole Hepatic Segment of Inferior Vena Cava].